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Summary Statement: This study used laser speckle flowgraphy to analyze the 
relationship between retinal blood flow and aqueous vascular endothelial growth 
factor (VEGF) concentration in central retinal vein occlusion. A correlation was 
observed between lower blood flows in large vessels at the optic disc and higher 
aqueous VEGF concentrations. 
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Abstract 
Purpose: Since laser speckle flowgraphy (LSFG) can measure blood flow 
distribution in the ocular fundus, we analyzed the relationship between retinal 
blood flow and aqueous vascular endothelial growth factor (VEGF) 
concentration in central retinal vein occlusion (CRVO). 
Methods: This prospective observational study examined 45 eyes of 45 CRVO 
patients prior to treatment. Blood flow in large vessels around and at the optic 
disc, aqueous VEGF concentration, and arteriovenous passage time were 
examined. Blood flow was evaluated as mean blur rate (MBR) by LSFG. 
Results: Fluorescein angiography found 20 ischemic and 25 non-ischemic type 
eyes. Aqueous VEGF concentration in the ischemic type was significantly higher 
than that in the non-ischemic type (P = 0.01). Arteriovenous passage time was 
significantly correlated to the logarithm of the aqueous VEGF concentration (P = 
0.0001). MBR of the affected eye / MBR of the unaffected eye of the ischemic 
type was significantly lower than the non-ischemic type (P = 0.039). Additionally, 
MBR was significantly correlated both to the logarithm of the aqueous VEGF 
concentration (P < 0.0001) and to the arteriovenous passage time (P = 0.0001). 
Conclusion: LSFG may be useful for predicting aqueous VEGF concentration 
and severity of CRVO. 
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INTRODUCTION 
Central retinal vein occlusion (CRVO) is an ophthalmologic vascular disorder 
that is the leading cause of visual loss due to macular edema or neovascular 
glaucoma. Of the two CRVO types, visual outcomes have historically been 
reported to be good in non-ischemic CRVO, while they are poor in ischemic 
CRVO.1 Vascular endothelial growth factor (VEGF) is related to the CRVO 
pathology. Induction of VEGF and pro-inflammatory cytokines by vascular 
occlusion has been shown to be associated with a breakdown of the 
blood-retinal barrier.2 VEGF also causes macular edema, which results in a poor 
visual acuity. It has been reported that the anti-VEGF agent, ranibizumab and 
aflibercept, significantly improved the visual acuity in eyes with macular edema 
after branch retinal vein occlusion (BRVO) or CRVO.3-5 
Ocular blood flow measurements are a commonly used parameter in a 
variety of ophthalmic diseases. The methodologies used to obtain ocular blood 
flow measurements can involve both invasive and noninvasive techniques. For 
example, the dye dilution method6 is an invasive technique, while color Doppler 
imaging,7 laser Doppler velocimetry,8 laser speckle flowgraphy (LSFG) 
(LSFG-Navi, Softcare, Fukuoka, Japan),9-16 and the retinal functional imager 
methodologies17 are considered to be noninvasive techniques. The LSFG device 
has been used to visualize blood flow distributions in the ocular fundus.12 LSFG 
is convenient for measuring blood flows and thus, can be utilized for clinical 
applications. Therefore, we used this instrument to analyze the relationship 




This prospective study was conducted on 45 eyes of 45 CRVO patients (18 
females, 27 males) with no history of previous treatment. Exclusion criteria 
consisted of cases of poor measurement (cataract with severe opacity, vitreous 
hemorrhage, poor mydriasis, corneal opacity), and previous vitreoretinal surgery. 
After providing informed consent, all patients were evaluated for blood flow in the 
large vessels at the optic disc, aqueous VEGF concentration, and arteriovenous 
passage time. The blood flow was evaluated as the mean blur rate (MBR) by 
LSFG. Aqueous humor of the VEGF concentration was evaluated by an 
enzyme-linked immunosorbent assay. Arteriovenous passage time was 
evaluated by fluorescein angiography using a Heidelberg Retina Angiograph II 
(Heidelberg Engineering GmbH, Heidelberg, Germany). A previous study that 
used fluorescein angiography to investigate CRVO showed that the ischemic 
type of CRVO was observed in more than 10 disc areas of the nonperfusion 
areas.18 
Our current research followed the tenets of the Declaration of Helsinki, with 
approval for this study obtained from the Ethics Committee of the Nagasaki 
University School of Medicine. 
 
Instrument 
The methodology used by the LSFG instrument is based on the laser speckle 
phenomenon.12 The most current instrument available now uses a fundus 
camera equipped with a diode laser (wavelength, 830 nm) and a highly sensitive 
charge-coupled device (CCD) camera (750 × 360 pixels), which has a scanning 
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speed of 30 frames per second. To observe the blood flow in the fundus, the 
area of interest is first illuminated by a wide laser spot, which causes the 
back-scattered laser from the spot to form a speckled pattern in the image plane 
of the fundus. The intensity variation of the pattern is then detected by the CCD 
camera, with the viewable area corresponding to a field of 8.6 × 4.6 mm (21° 
visual angle of the fundus camera) in the human fundus.12 
 
Mean Blur Rate Measurement 
In the present study, 30 min prior to taking the measurements, the patient’s 
pupils were dilated using one drop of Mydrin P® (1% tropicamide and 2.5% 
phenylephrine hydrochloride; Santen Pharmaceutical, Osaka, Japan). During 
the measurement collection period, patients were asked to focus on a target light 
in order to fix the line of sight, thereby ensuring capture of the image speckles 
from the optic disc. The relative blood flow velocity (AU) was evaluated by the 
MBR and displayed as a 2-dimensional color-coded map. After circling the area 
around the optic disc, we then investigated the MBR of the major vessel (artery 
and vein) within this circle. Figure 1 shows a composite map (Figure 1A) within 
the optic disc and its histogram (Figure 1B). The vertical axis corresponds to the 
number of pixels, while the horizontal axis corresponds to the MBR in the 
histogram. The appropriate threshold between the tissue and vessel areas was 
automatically determined by the software. The histogram seen in Figure 1D 
shows the division between the tissue and vessel areas that was determined 
from the image shown in Figure 1C. The area to the left of the threshold line 
corresponds to the tissue area of the optic disc (black area in Figure 1C), while 
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the area to the right corresponds to the vessel area of the optic disc (white area 
in Figure 1C). Since the MBR in the vessel area includes the choroidal blood flow, 
we subtracted the mean MBR in the tissue area (MT) from the mean MBR in the 
vessel area (MV). Thus, the MBR used to evaluate the blood flow in the retinal 
vessel excluded the choroidal blood flow. 
Measurements were performed three times, with the average used as the 
MBR value. Since the eye position was recorded using LSFG measurements, 
this made it possible to capture the same area during each of the subsequent 
examinations. 
To examine the correlation between the preoperative MBR and the 
postoperative MBR in this study, we calculated the percentage of the 
preoperative MBR of the same eye. For comparisons with the MBR of different 
eyes, cases of comparison with other patients, or with an unaffected eye, we 
used the percent of the MBR of the unaffected eye. 
 
Statistical analysis 
All results are expressed as the means ± standard deviation. Statistical 
analysis was performed using Statflex ver. 5.0 software (Artech Corporation, 
Osaka, Japan). Statistical significance was considered at P < 0.05. 
 
RESULTS 
A total of 45 unilateral CRVO patients were enrolled in this study. Mean age 
was 69 ± 10 years old. The average CRVO duration was 1.2 ± 1.6 months 
(range, 0.1 to 6 months) (Table). 
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MBR of the affected eye / MBR of the unaffected eye (81.2 ± 23.0%) was 
significantly lower than the MBR of the fellow eyes (100%) (P < 0.0001, paired 
t-test) (Figure 2). After first classifying the 45 cases of CRVO as either 
non-ischemic type (25 cases) or ischemic type (20 cases), we evaluated the 
relationship between ischemia, blood velocity, and aqueous VEGF 
concentration. 
The relationship between ischemia and blood velocity is shown in Figure 3A. 
MBR of the affected eye / MBR of the unaffected eye in the ischemic type (73.3 ± 
20.9%) was significantly lower than that in the non-ischemic type (87.6 ± 24.0%) 
(P = 0.039, unpaired t-test) (Figure 3A). VEGF is an important cytokine that 
causes macular edema. VEGF is produced in response to the ischemia that 
results from the vascular occlusion; therefore, we decided to evaluate the 
relationship between ischemia and the aqueous VEGF concentration. Aqueous 
VEGF concentration in the ischemic type (1945 ± 2216 pg/ml) was significantly 
higher than that found in the non-ischemic type (515 ± 495 pg/ml) (P = 0.01, 
unpaired t-test) (Figure 3B). 
Since the arteriovenous passage time is correlated to the degree of ischemia, 
we subsequently evaluated the relationship between the arteriovenous passage 
time and the aqueous VEGF concentration. Results indicated a significant 
correlation between the arteriovenous passage time and the logarithm of the 
aqueous VEGF concentration (R2 = 0.28, P = 0.0001) (Figure 4). To examine 
whether the blood velocity is also correlated with ischemia, we evaluated the 
relationship between the arteriovenous passage time and the blood velocity. Our 
analysis indicated that the MBR was significantly correlated to the arteriovenous 
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passage time (R2 = 0.30, P = 0.0001) (Figure 5). Our final comparison of the 
blood velocity and aqueous VEGF concentration showed that the MBR was 
significantly correlated to the logarithm of the aqueous VEGF concentration (R2 = 
0.32, P = 0.0001) (Figure 6). 
 
DISCUSSION 
LSFG measurements and analysis can be easily performed, have good 
reproducibility, and are noninvasive; therefore, it was used in the current study to 
evaluate blood velocity. Since we investigated the MBR of the major vessel 
(artery and vein) located within a circle on the optic disc, our study was also able 
to measure and analyze the mean blood velocity of the artery and vein, which 
reflected the total retinal circulation. While investigations of the blood velocity of 
the major vessels on the disc may reflect the entire retinal circulation, we believe 
it is better to separately measure the blood velocity of the artery and vein, as it 
can be difficult to automatically separate and measure the blood velocity. 
MBR of the affected eye / MBR of the unaffected eye was significantly lower 
than the MBR of the fellow eyes. Many previous studies have reported finding 
that the blood velocity of CRVO was lower than that observed in the normal eye. 
When using color Doppler imaging, Michelson et al. reported the mean blood 
velocity of the central retinal vein (CRV) in CRVO (2.1 cm/sec) was significantly 
slower than that found in the controls (3.3 cm/sec).19 In addition, they also 
reported finding no significant difference between the blood velocity of the 
central retinal artery in CRVO (8.2 cm/sec) and that in the controls (9.3 cm/sec). 
Crama et al. have also reported that color Doppler imaging showed a decrease 
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in the mean blood velocity of the CRV in CRVO (4.9 cm/sec) as compared to the 
controls (8 cm/sec).20 Horio et al. found that blood velocity in the vein in CRVO 
(28.5 pixel2/sec) was slower than that of the fellow eyes (39.9 pixel2/sec) when 
using the dye dilution technique.21 In the current study, the MBR of the affected 
eye / MBR of the unaffected eye was 81.2%. Our results indicate that there was 
a slightly faster rate than that observed in the other studies. For example, the 
Michelson study determined the percentage to be 63%,19 while the Crama study 
found 61%,20 and the Horio study found 71%.21 The reason why our blood 
velocity results were faster than those previously reported was most likely that 
we measured the blood velocity in both the vein and artery. It might also be 
possible that our study contained higher numbers of the non-ischemic type of 
CRVO as compared to the other reports. 
We also examined the number of ischemic and non-ischemic types for CRVO, 
and then compared the blood velocity between these two types. Our results 
showed that the MBR of the affected eye / MBR of the unaffected eye in the 
ischemic type was significantly lower than that found for the non-ischemic type. 
Williamson et al. reported that the values of the maximum and minimum blood 
velocities of the CRV were reduced in accordance with the degree of the 
increase in the ischemia, with significantly lower values found in ischemic versus 
non-ischemic eyes.22 Arséne et al. have also reported that the minimum blood 
velocity of CRV in the ischemic type of CRVO (1.83 cm/sec) was lower than that 
of the non-ischemic type (2.28 cm/sec).23 
Our study also indicated that the aqueous VEGF concentration for the 
ischemic type was significantly higher than that for the non-ischemic type. Noma 
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et al. found that the vitreous levels of VEGF were significantly higher in ischemic 
versus non-ischemic CRVO patients.24 Moreover, after demonstrating that the 
aqueous humor levels of the cytokines were correlated with the vitreous levels, 
they further proposed that the aqueous levels might be indicative of the severity 
of the macular edema in BRVO.25 Our present results are in agreement with the 
findings of Noma’s previous studies. 
We additionally evaluated the relationship between the arteriovenous 
passage time and the aqueous VEGF concentration. Our results showed there 
was a significant correlation between the longer arteriovenous passage times 
and the higher aqueous VEGF concentrations. To the best of our knowledge, no 
previous studies in human subjects have evaluated the relationship between the 
arteriovenous passage time and the aqueous VEGF concentration. 
In the final step of our study, we examined the relationship between the blood 
velocity and the aqueous VEGF concentration. Our results indicated there was a 
significant correlation between lower blood velocities and higher aqueous VEGF 
concentrations. Williamson et al. demonstrated that a minimum blood velocity of 
less than 3.0 cm/sec in CRVO patients was highly predictive of the development 
of iris neovascularization, with a sensitivity rate of 75% and a specificity rate of 
86%.22 When all of these results are taken together, our findings suggest that it 
might be possible to determine the presumed aqueous VEGF concentration from 
the blood velocity. Thus, CRVO prognosis could be inferred from this presumed 
aqueous VEFG concentration. 
There were several limitations for the present study, including having only a 
small number of cases, and not confirming whether ischemic CRVO met 
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Hayreh’s high risk criteria.26, 27 In addition, we did not estimate nonperfusion 
areas quantitatively. When using the LSFG methodology, it is important to 
remember that the MBR is only able to provide relative and not absolute values 
for the blood velocity. Therefore, when comparing different eyes in this study, we 
only evaluated the differences using percentages derived from the following 
formula: MBR of the affected eye / MBR of the unaffected eye. 
In conclusion, lower blood flows in large vessels in the optic disc were 
correlated to the higher aqueous VEGF concentrations in CRVO. Thus, LSFG 
may be a useful device for determining presumed aqueous VEGF 
concentrations. This is a very important finding, as VEGF is used in the visual 
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FIGURE CAPTIONS  
Figure 1. A composite map and a histogram within the optic disc was created 
using LSFG. A) A false-color composite map within the optic disc is shown. Red 
indicates a faster blood flow, while blue indicates a slower blood flow. B) A 
histogram within the optic disc is shown. The vertical axis corresponds to the 
number of pixels, while the horizontal axis corresponds to the MBR. C) 
Representative binary format images for segmentation between the vessel 
(white area) and tissue (black area) are shown. D) The histogram was analyzed 
using image viewer software that utilizes an automated definitive threshold. The 
area to the left of the threshold line corresponds to the tissue of the optic disc 
(black area in Fig. 1C), while the area to the right of the line corresponds to the 
vessel of the optic disc (white area in Fig. 1C). 
 
Figure 2 
MBR of the affected eye / MBR of the unaffected eye (81.2 ± 23.0%) was 
significantly lower than the MBR of the fellow eyes (100%). 
 
Figure 3 
A) The relationship between ischemia and blood velocity. The vertical axis 
represents the ratio of the MBR of the affected eye to the MBR of the unaffected 
eye. Blood velocity in the ischemic type CRVO was significantly lower than that 
in the non-ischemic type CRVO. B) The relationship between the ischemia and 
the aqueous VEGF concentration. Aqueous VEGF concentration in ischemic 
type eyes (1945 ± 2216 pg/ml) was significantly higher than that in the 
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non-ischemic type eyes (515 ± 495 pg/ml). 
 
Figure 4 
This figure shows the relationship between the arteriovenous passage time and 
the logarithm of the aqueous VEGF concentration. Arteriovenous passage time 
was significantly correlated to the logarithm of the aqueous VEGF concentration 
(R2 = 0.28, P = 0.0001). 
 
Figure 5 
This figure shows the relationship between the arteriovenous passage time and 
the blood velocity. MBR was significantly correlated to the arteriovenous 
passage time (R2 = 0.30, P = 0.0001). 
 
Figure 6 
This figure shows the blood velocity and the logarithm of the aqueous VEGF 
concentration. MBR was significantly correlated to the logarithm of the aqueous 








TABLE. Characteristics of patients with central retinal vein occlusion  
Demographics 
Age (years) (mean ± SD) 
Sex (female:male) 
 





Systolic blood pressure (mm Hg) (mean ± SD) 
Diastolic blood pressure (mm Hg) (mean ± SD) 
Ischemic type of CRVO (eye) 




133 ± 15 
74 ± 11 
20 
1.2 ± 1.6 
SD = standard deviation; CRVO = central retinal vein occlusion 
